Lifecycle pricing GPI serves life sciences teams with pricing and market access decisions across the full drug lifecycle, presenting opportunities to upsell value forecasting, horizon analytics, and price impact studies for portfolio optimization.

Data driven edge Proprietary datasets and forecasting methods position GPI to partner with biopharma firms seeking rapid, defensible pricing decisions; potential for expanding data integration services and API based workflows.

Enterprise integrations GPI Connect offers end-to-end custom API access; target large pricing and access teams needing seamless integration with internal systems, dashboards, and workflows to reduce manual handoffs.

Strategic partnerships Historical collaboration with Model N and emphasis on market access suggests opportunities to co-sell with cloud revenue management and pricing software providers.

Growing analytics footprint Recent product updates to GPI Pulse and Horizon indicate momentum in analytics offerings; position for upsell to expanding teams prioritizing rapid value assessment and policy signals.